UCB - Operating Expenses

Stock Price
260.70
Daily Change
0.10 0.04%
Monthly
10.98%
Yearly
41.30%
Q1 Forecast
249.19

UCB reported EUR2.36B in Operating Expenses for its fiscal semester ending in December of 2024.





Operating Expenses Change Date
Alcon AG USD 2.28B 67M Sep/2025
Almirall EUR 517.43M 43.18M Jun/2025
Amarin USD 51.37M 14.6M Sep/2025
argenx SE USD 776.99M 32.87M Sep/2025
AstraZeneca USD 16.69B 5.74B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Orion EUR 302.2M 9.7M Sep/2025
Recordati EUR 466.68M 27.25M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.36B 108M Dec/2024
Unibail Rodamco EUR 621.2M 558.5M Jun/2025